Virtus ETF Advisers’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-27,357
| Closed | -$1.27M | – | 460 |
|
|
2019
Q2 | $1.27M | Sell |
27,357
-21,565
| -44% | -$999K | 0.27% | 149 |
|
|
2019
Q1 | $1.19M | Buy |
48,922
+10,443
| +27% | +$255K | 2.54% | 3 |
|
|
2018
Q4 | $548K | Buy |
38,479
+12,195
| +46% | +$174K | 0.09% | 69 |
|
|
2018
Q3 | $400K | Sell |
26,284
-18,803
| -42% | -$286K | 0.04% | 163 |
|
|
2018
Q2 | $757K | Sell |
45,087
-23,676
| -34% | -$398K | 0.67% | 65 |
|
|
2018
Q1 | $1.12M | Buy |
68,763
+36,645
| +114% | +$598K | 0.97% | 24 |
|
|
2017
Q4 | $411K | Sell |
32,118
-10,118
| -24% | -$129K | 0.52% | 49 |
|
|
2017
Q3 | $520K | Buy |
42,236
+3,863
| +10% | +$47.6K | 0.07% | 84 |
|
|
2017
Q2 | $321K | Buy |
38,373
+6,350
| +20% | +$53.1K | 0.05% | 105 |
|
|
2017
Q1 | $286K | Buy |
32,023
+3,070
| +11% | +$27.4K | 0.05% | 142 |
|
|
2016
Q4 | $254K | Sell |
28,953
-46,147
| -61% | -$405K | 0.08% | 137 |
|
|
2016
Q3 | $507K | Hold |
75,100
| – | – | 0.25% | 71 |
|
|
2016
Q2 | $267K | Buy |
75,100
+8,724
| +13% | +$31K | 0.2% | 73 |
|
|
2016
Q1 | $196K | Buy |
+66,376
| New | +$196K | 0.27% | 87 |
|